Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDR | P35968 | 10/20 | 0.62 |
| ▸ | EGFR | P00533 | 8/20 | 0.62 |
| ▸ | PDGFRB | P09619 | 8/20 | 0.62 |
| ▸ | PDGFRA | P16234 | 3/20 | 0.59 |
| ▸ | TUBB3 | Q13509 | 5/20 | 0.47 |
| ▸ | ABCB1 | P08183 | 4/20 | 0.47 |
| ▸ | TUBB4A | P04350 | 1/20 | 0.47 |
| ▸ | TUBB | P07437 | 1/20 | 0.47 |
| ▸ | TUBA3C | P0DPH7 | 1/20 | 0.47 |
| ▸ | TUBA1B | P68363 | 1/20 | 0.47 |
| ▸ | TUBA4A | P68366 | 1/20 | 0.47 |
| ▸ | TUBB4B | P68371 | 1/20 | 0.47 |
| ▸ | TUBB2A | Q13885 | 1/20 | 0.47 |
| ▸ | TUBB8 | Q3ZCM7 | 1/20 | 0.47 |
| ▸ | TUBA3E | Q6PEY2 | 1/20 | 0.47 |
| ▸ | TUBA1A | Q71U36 | 1/20 | 0.47 |
| ▸ | TUBA1C | Q9BQE3 | 1/20 | 0.47 |
| ▸ | TUBB6 | Q9BUF5 | 1/20 | 0.47 |
| ▸ | TUBB2B | Q9BVA1 | 1/20 | 0.47 |
| ▸ | TUBB1 | Q9H4B7 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Verubulin SCHEMBL2232326 | 0.77 | KDR (1.00) | KDREGFRPDGFRBPDGFRATUBB3 | |
| Verubulin SCHEMBL29379614 | 0.77 | KDR (1.00) | KDREGFRPDGFRBPDGFRATUBB3 | |
| Verubulin SCHEMBL29505369 | 0.76 | KDR (0.97) | KDREGFRPDGFRBPDGFRATUBB3 | |
| Verubulin SCHEMBL2395194 | 0.76 | KDR (0.97) | KDREGFRPDGFRBPDGFRATUBB3 | |
| SCHEMBL1366266 | 0.75 | TUBB3 (0.61) | KDREGFRPDGFRBPDGFRATUBB3 | |
| SCHEMBL3124173 | 0.74 | KDR (1.00) | KDREGFRPDGFRBPDGFRA | |
| SCHEMBL14207894 | 0.74 | KDR (0.57) | KDREGFRPDGFRBPDGFRATUBB3 | |
| SCHEMBL3112156 | 0.73 | KDR (0.66) | KDREGFRPDGFRBPDGFRATUBB3 | |
| SCHEMBL4845879 | 0.73 | KDR (0.62) | KDREGFRPDGFRBPDGFRATUBB3 | |
| SCHEMBL3114812 | 0.71 | KDR (0.66) | KDREGFRPDGFRBPDGFRATUBB3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120264768-A1 | BICYCLIC AND TRICYCLIC PYRIMIDINE TYROSINE KINASE INHIBITORS WITH ANTITUBULIN ACTIVITY AND METHODS OF TREATING A PATIENT | DUQUESNE UNIVERSITY OF THE HOLY SPIRIT | 2012-10-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120264768-A1 | BICYCLIC AND TRICYCLIC PYRIMIDINE TYROSINE KINASE INHIBITORS WITH ANTITUBULIN ACTIVITY AND METHODS OF TREATING A PATIENT | TK1, UACA, DSTYK | KDR 32/4885EGFR 9/4885PDGFRB 283/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.